authors Rose, Liam Vogelstein, Bert Athey, Susan Vogelstein, Joshua T Konig, Maximilian F Wagner, Todd H Laura A Graham, PhD, MPH Koenecke, Allison Powell, Michael Xiong, Ruoxuan Shen, Zhu Mench, Brett Kinzler, Kenneth W Bettegowda, Chetan
Keywords COVID-19 alpha-1-adrenergic receptor antagonist coronavirus disease infectious disease off-label drug use